NOVARTIS AG-SPONSORED ADR (NVS) Stock News

USA - NYSE:NVS - US66987V1098 - ADR

130.5 USD

+3.3 (+2.59%)

Last: 11/11/2025, 8:04:00 PM

130.62 USD

+0.12 (+0.09%)

Pre-Market: 11/12/2025, 8:45:22 AM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

NVS Latest News, Press Relases and Analysis

All

Press Releases

16 days ago - By: Chartmill - Mentions: IRBT QCOM TSLA RNA ...

News Image

Wall Street Soars as Qualcomm Ignites the AI Race

2 days ago - By: Stocktwits - Mentions: DFAX QLTI

News Image

Novartis Opens New Manufacturing Facility In California In Bid To Increase US Presence

7 days ago - By: Investor's Business Daily - Mentions: CELC

Celcuity Eyeing Cancer Treatment Riddle. Stock Flys 534% This Year.

9 days ago - By: Benzinga - Mentions: TERN

Terns Pharmaceuticals' Leukemia Drug Seen As Potential Disruptor In CML Treatment Landscape, Analyst Upgrades

9 days ago - By: The Motley Fool - Mentions: IEFA VEU SAP BABA ...

iShares Core MSCI EAFE ETF (IEFA) Focuses on Developed Markets While Vanguard FTSE All-World ex-US ETF (VEU) Looks Globally

10 days ago - By: The Motley Fool - Mentions: VEA SPDW SAP TM

The Vanguard FTSE Developed Markets ETF (VEA) Offers Broader Diversification Than the SPDR Portfolio Developed World ex-US ETF (SPDW)

13 days ago - By: Zacks Investment Research - Mentions: AZN BIIB IONS

Ionis Beats Q3 Earnings & Sales Estimates, Raises 2025 Outlook

14 days ago - By: Benzinga

Is the Market Bullish or Bearish on Novartis AG?

14 days ago - By: Zacks Investment Research

Why Novartis (NVS) is a Top Value Stock for the Long-Term

14 days ago - By: Investor's Business Daily - Mentions: AAPL UTHR

United Therapeutics Dips As Bread-And-Butter Drug Comes Up Short

15 days ago - By: Investor's Business Daily

Novartis Slips As Generics Champ At Heart-Failure Drug In Mixed Third Quarter